SHR-2002

· Atridia Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-2002, covering 2024-06-04 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors [Phase 1]